journal article·2020-10-07

Biomineralized Biohybrid Algae for Tumor Hypoxia Modulation and Cascade Radio-Photodynamic Therapy

Wanlin Li, Danni Zhong, Shiyuan Hua, Zhen Du, Min Zhou

ACS Applied Materials & Interfaces· Volume 12· Issue 40
Publisher page

Abstract

Biomineralization of biomaterials has shown extraordinary potential in cancer treatment, but the exploration of their in vivo applications is still insufficient. Here, we report a biohybrid microalgae system using a biomineralization approach to improve their biocompatibility, while keeping their living activities for radiation and photodynamic synergistic therapy in breast cancer. The biohybrid algae (Algae@SiO2) synthesized by a one-step biomimetic silicification method could significantly enhance their cytotoxicity and tolerance, improving the living activity in the tumor area. The innate chlorophyll and unique optical property make Algae@SiO2 possess dual imaging ability, namely, photoacoustic imaging and fluorescence imaging. Algae@SiO2 accumulated in tumor sites could generate oxygen in situ by external light-mediated photosynthesis, relieve tumor hypoxia, and then enhance the efficiency of radiation therapy. As a natural photosensitizer, the released chlorophyll from Algae@SiO2 could provide reactive oxygen species to kill the cancer cells for the cascaded photodynamic therapy. The significant suppression of tumor growth in the mice bearing 4T1 tumor successfully demonstrates the promising anti-tumor effect of the Algae@SiO2-mediated synergistic therapy. Our results show that biohybrid algae, integrated with PAI/FI dual imaging, radiosensitization, and cascaded photothermal therapy, is a promising multifunctional efficient biosystem for cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Protist diversity and phylogeny

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China

Institute of Translational Medicine, Zhejiang University, Hangzhou 310009, China

State Key Laboratory of Modern Optical Instrumentations, Zhejiang University, Hangzhou 310058, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (57)

Show source-provided references
1. 10.1111/j.1582-4934.2011.01258.x10.1111/j.1582-4934.2011.01258.x ↗
2. 10.1016/S1535-6108(03)00336-210.1016/S1535-6108(03)00336-2 ↗
3. 10.1038/sj.bjc.660492910.1038/sj.bjc.6604929 ↗
4. 10.1038/nrc225510.1038/nrc2255 ↗
5. 10.1038/nrc306410.1038/nrc3064 ↗
6. 10.1038/s41467-019-14052-x10.1038/s41467-019-14052-x ↗
7. 10.1038/ncb333010.1038/ncb3330 ↗
8. 10.1038/s41575-019-0247-210.1038/s41575-019-0247-2 ↗
9. 10.1038/nrd400310.1038/nrd4003 ↗
10. 10.1158/0008-5472.CAN-07-687110.1158/0008-5472.CAN-07-6871 ↗
11. 10.1126/scitranslmed.300514810.1126/scitranslmed.3005148 ↗
12. 10.1259/0007-1285-9-105-60610.1259/0007-1285-9-105-606 ↗
13. 10.1002/adma.20160616710.1002/adma.201606167 ↗
14. 10.1021/acs.chemrev.6b0052510.1021/acs.chemrev.6b00525 ↗
15. 10.1021/acsnano.8b0203810.1021/acsnano.8b02038 ↗
16. 10.1080/1073119090304321810.1080/10731190903043218 ↗
17. 10.1200/JCO.2011.35.931510.1200/JCO.2011.35.9315 ↗
18. 10.1158/1078-0432.CCR-13-178710.1158/1078-0432.CCR-13-1787 ↗
19. 10.1038/s41598-020-59945-w10.1038/s41598-020-59945-w ↗
20. 10.1016/j.scitotenv.2018.02.02010.1016/j.scitotenv.2018.02.020 ↗
21. 10.1007/s11033-018-4266-910.1007/s11033-018-4266-9 ↗
22. 10.1016/j.matt.2020.04.02210.1016/j.matt.2020.04.022 ↗
23. 10.1126/sciadv.160307810.1126/sciadv.1603078 ↗
24. 10.1038/nri364610.1038/nri3646 ↗
25. 10.1021/acsnano.7b0367510.1021/acsnano.7b03675 ↗
26. 10.1021/acs.jmedchem.7b0167810.1021/acs.jmedchem.7b01678 ↗
27. 10.1038/sj.bjc.660145710.1038/sj.bjc.6601457 ↗
28. 10.1016/j.msec.2017.12.01210.1016/j.msec.2017.12.012 ↗
29. Wunderlich A. L. M. · Brazilian J. Med. Biol. Res. · 2020 · 53 · 1
30. 10.1021/acs.nanolett.0c0109810.1021/acs.nanolett.0c01098 ↗
31. 10.1126/science.261.5126.128610.1126/science.261.5126.1286 ↗
32. 10.1002/adma.20160590310.1002/adma.201605903 ↗
33. 10.1021/acs.nanolett.7b0302110.1021/acs.nanolett.7b03021 ↗
34. 10.1002/adhm.20200004610.1002/adhm.202000046 ↗
35. 10.1039/b805407j10.1039/b805407j ↗
36. 10.1039/C6CC09680H10.1039/C6CC09680H ↗
37. 10.1002/smll.20090178910.1002/smll.200901789 ↗
38. 10.1021/acsbiomaterials.9b0046410.1021/acsbiomaterials.9b00464 ↗
39. 10.1021/cm402592t10.1021/cm402592t ↗
40. 10.1021/nn405092w10.1021/nn405092w ↗
41. 10.1002/anie.20060448810.1002/anie.200604488 ↗
42. 10.1021/nl504044p10.1021/nl504044p ↗
43. 10.1021/acs.bioconjchem.9b0042910.1021/acs.bioconjchem.9b00429 ↗
44. 10.1021/acs.nanolett.8b0240910.1021/acs.nanolett.8b02409 ↗
45. 10.1021/acs.nanolett.8b0393610.1021/acs.nanolett.8b03936 ↗
46. Chen C. · Adv. Mater. · 2019 · 31 · 1
47. 10.1002/adma.20150228510.1002/adma.201502285 ↗
48. 10.1002/adma.20180633110.1002/adma.201806331 ↗
49. 10.1002/advs.20190121110.1002/advs.201901211 ↗
50. 10.1007/s00262-003-0443-210.1007/s00262-003-0443-2 ↗
51. 10.1080/08820139.2017.136033910.1080/08820139.2017.1360339 ↗
52. 10.1073/pnas.111374410910.1073/pnas.1113744109 ↗
53. 10.1016/j.yexmp.2006.06.00710.1016/j.yexmp.2006.06.007 ↗
54. 10.1002/stem.553003020310.1002/stem.5530030203 ↗
55. 10.1038/nature0487210.1038/nature04872 ↗
56. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
57. 10.1158/0008-5472.CAN-19-045810.1158/0008-5472.CAN-19-0458 ↗